1. Home
  2. ZWS vs IBRX Comparison

ZWS vs IBRX Comparison

Compare ZWS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$45.89

Market Cap

8.4B

Sector

Industrials

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.46

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZWS
IBRX
Founded
1900
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.2B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
ZWS
IBRX
Price
$45.89
$8.46
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$53.67
$12.57
AVG Volume (30 Days)
690.5K
8.4M
Earning Date
04-21-2026
05-08-2026
Dividend Yield
0.86%
N/A
EPS Growth
25.00
38.71
EPS
0.35
N/A
Revenue
$1,530,500,000.00
$113,288,000.00
Revenue This Year
$6.90
$88.59
Revenue Next Year
$5.13
$131.15
P/E Ratio
$130.66
N/A
Revenue Growth
19.40
668.31
52 Week Low
$43.06
$1.95
52 Week High
$55.00
$12.43

Technical Indicators

Market Signals
Indicator
ZWS
IBRX
Relative Strength Index (RSI) 36.41 57.26
Support Level $45.86 $6.68
Resistance Level $46.24 $8.51
Average True Range (ATR) 0.90 0.40
MACD -0.10 0.02
Stochastic Oscillator 18.70 68.10

Price Performance

Historical Comparison
ZWS
IBRX

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: